Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features

To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Microbiol
Autori principali:	Fonjungo, Peter N., Mpoudi, Eitel N., Torimiro, Judith N., Alemnji, George A., Eno, Laura T., Lyonga, Esther J., Nkengasong, John N., Lal, Renu B., Rayfield, Mark, Kalish, Marcia L., Folks, Thomas M., Pieniazek, Danuta
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2002
Soggetti:	Virology
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120267/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11880402/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.3.837-845.2002
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!